Welcome to My Blog
Here is a masonry blog layout with no sidebarSBI, ICICI Bank, HDFC Bank remain systemically important banks: RBI
DHFL resolution: Lenders approve Piramal”s $ 5 billion bid
Its large lenders are SBI, including SBI Singapore with Rs 10,083 crore exposure. Others are Bank of India (Rs 4,125 crore), Canara Bank (Rs 2,681 crore), NHB (Rs 2,434 crore), Union Bank (Rs 2,378 crore), Syndicate Bank (Rs 2,229 crore), Bank of Baroda (Rs 2,075 crore), Indian Bank (Rs 1,552 crore), Central Bank (Rs 1,389 crore), IDBI Bank (Rs 999 crore) and HDFC Bank (Rs 361 crore).
The company has also exposures from insurance companies including Life Insurance Corporation and New India Insurance which have already taken hits on the account by showing it as a non-performing assets…
COVID-19: India records lowest fatalities in eight months
Total speeds up renewables push with $2.5 billion investment in Indian solar power
Total is trying to reduce its dependence on oil and shift towards electricity and renewable energy. It aims to have 35 gigawatts (GW) of gross renewable energy generation capacity by 2025 from around 9 GW now
“Our entry into AGEL is a major milestone in our strategy in the renewable energy business in India put in place by both parties,” Total CEO and Chairman Patrick Pouyanne said.
Don’t join WhatsApp if not accepting new policy: HC
AI likely to replace humans in cybersecurity space by 2030
Health worker dies in Moradabad day after receiving COVID shot
Chief Medical Officer Milind Chander Garg cited a postmortem report and said that the cause of death was cardiac disease.
Refuting the claim of the health authorities, the family members of the deceased said that he was never faced cardiac problem and he was quite healthy except the fever and cough.
No ‘serious or severe’ adverse effect post COVID-19 immunisation report so far: Govt
A total of 3,81,305 beneficiaries have so far been vaccinated for COVID-19 and 580 adverse events following immunisation were reported in the country till now, the Union health ministry said on Monday.
He said a cumulative 580 adverse events following immunisation (AEFI) and seven cases of hospitalisation have so far been reported in the country since the nationwide COVID-19 inoculation drive began on January 16.
Indian companies consider buying vaccines for employees
World on brink of “Catastrophic Moral Failure” on vaccines: WHO Chief
The global scramble for shots has intensified as more infectious virus variants circulate.Tedros said more than 39 million vaccine doses had been administered in 49 higher-income countries whereas just 25 doses had been given in one poor country.
He said even as some countries pronounced reassuring words on equitable access, they were prioritising their own deals with manufacturers, driving up prices and trying to jump the queue.
Maha among 3 states with highest deaths in road accidents: Govt
Steel companies engage with vaccine makers for bulk supply of doses for employees
State-owned RINL and Steel Authority of India Limited (SAIL) have sent details of its employees to the administration and who will be vaccinated based on priority.
Both SAIL and RINL also run hospitals at their plant sites.
A Tata Steel spokesperson said the company has been working very closely with the government and respective state governments of Jharkhand and Odisha from the start of the pandemic and serving the community with medical facilities at various locations of its operations.
India reports 70 lakh burn injuries annually with 1.4 lakh mortality rate:Harsh Vardhan
“Burn injury is one of the biggest causes of workforce loss and this is an issue of concern for countries like India. The nation reports as many as 70 lakh burn injuries annually with a mortality rate as high as 1.4 lakh per year and an additional 2.4 lakh patients end up with severe deformities. Due to its large population, most of the burn care facilities are overburdened and the state-of-the-art burn care is negligible. There is a dire need for a healthcare facility that can provide high-quality care for a large fraction of the population. The new Burns and Plastic Surgery Block has been conceived with the vision of providing state-of-the-art care in the field of burns management and research at All India Institute of Medical Sciences, Delhi.,” Vardhan said at the inauguration ceremony.
Norway says no link between vaccine and post-jab deaths
The Norwegian Medicines Agency said last week that normal side effects from messenger RNA vaccines, such as fever and nausea, “may have contributed to a fatal outcome in some frail patients.”
A number of countries, including Norway’s neighbours Denmark, Finland, Iceland and Sweden, have reported post-vaccination deaths but no direct links to the vaccine have been established.
Allianz Risk Barometer 2021: Covid-19 trio tops global and Asia Pacific business risks
“The Allianz Risk Barometer 2021 is clearly dominated by the Covid-19 trio of risks. Business interruption, pandemic and cyber are strongly interlinked, demonstrating the growing vulnerabilities of our highly globalized and connected world,” says Joachim Müller, CEO of AGCS.
“The coronavirus pandemic is a reminder that risk management and business continuity management need to further evolve in order to help businesses prepare for, and survive, extreme events. While the pandemic continues to have a firm grip on countries around the world, we also have to ready ourselves for more frequent extreme scenarios, such as a global-scale cloud outage or cyber-attack, natural disasters driven by climate change or even another disease outbreak,” he said.
German specialists probing 10 deaths of people vaccinated against Covid-19
UK begins major trial for new inhaler-based Covid-19 treatment
“We need treatments as well as vaccines to fight highly pathogenic viruses such as SARS-CoV-2 [Covid-19]. Development of treatments like ours will remain necessary in cases where vaccines are not effective, for those who do not get vaccinated, and in case the virus mutates to the point where vaccines become less effective,” said Richard Marsden, CEO of Synairgen.